Safety, Tolerability, Pharmacokinetics and Efficacy of WOL071-007 in Atopic Dermatitis Patients

Clinical trial NCT02576093 · COMPLETED

Trial details

NCT number: NCT02576093
Sponsor: Dr. August Wolff GmbH & Co. KG Arzneimittel
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2014-03-01
Primary completion: 2015-07-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.